Insulin treatment in intensive care patients

Hormone Research

Volumn 71, Issue 1, 2009, Pages 2-11

  Derde, Sarah ^a   Vanhorebeek, Ilse ^a   Van Den Berghe, Greet ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Critical illness; Hyperglycemia; Hypoglycemia; Insulin; Metabolism

Indexed keywords

GLUCOSE; HETASTARCH; INSULIN; POTASSIUM;

CLASSIFICATION ALGORITHM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DRUG MEGADOSE; EMERGENCY PATIENT; ENDOTHELIAL DYSFUNCTION; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; LIPID METABOLISM; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHORT SURVEY; SURVIVAL; TREATMENT DURATION;

BLOOD GLUCOSE; CRITICAL CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 56749103249     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173736     Document Type: Short Survey

References (75)

1. Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000;46:335-342.
2. Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM: Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;58:921-924.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432.
5. Vanhorebeek I, Van den Berghe G: Diabetes of injury: novel insights. Endocrinol Metab Clin North Am 2006;35:859-872.
6. Wolfe RR, Durkot MJ, Allsop JR, Burke JF: Glucose metabolism in severely burned patients. Metabolism 1979;28:1031-1039.
7. Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M: Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987;317:403-408.
8. Mizock BA: Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995;98:75-84.
9. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001;17:107-124.
10. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
11. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-1353.
12. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van DA, Schetz M, Wouters PJ, Van den BG: Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006;27:2716-2724.
13. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE: Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006;34:612-616.
14. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
15. Grey NJ, Perdrizet GA: Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(suppl 2):46-52.
16. Reed CC, Stewart RM, Sherman M, Myers JG, Corneille MG, Larson N, Gerhardt S, Beadle R, Gamboa C, Dent D, Cohn SM, Pruitt BA Jr: Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007;204:1048-1054.
17. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van WE, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
18. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G: Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-489.
19. Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients. http://www.clinicaltrials.gov/ct/ show/NCT00107601. 2008.
20. Zander R, Boldt J, Engelmann L, Mertzlufft F, Sirtl C, Stuttmann R: The design of the VISEP trial. Critical appraisal (in German). Anaesthesist 2007;56:71-77.
21. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.
22. Brunkhorst FM, Kuhnt E, Engel C, Meier-Hellmann A, Ragaller M, Quintel M, Weiler N, Gründling M, Oppert M, Deufel T, Löffler M, Reinhart K: Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia - results from a randomized multicenter study (VISEP). http://webanae.med.uni-jena.de/WebObjects/DSGPortal. woa/WebServerResources/sepnet/dokumente/Brunkhorst.VISEP-Glucose-Weimar-2005. pdf 2008.
23. Van Cromphaut S, Wilmer A, Van den Berghe G: Management of sepsis. N Engl J Med 2007;356:1179-1181.
24. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-799.
25. Yusuf S, Mehta SR, Diaz R, Paolasso E, Pais P, Xavier D, Xie C, Ahmed RJ, Khazmi K, Zhu J, Liu L: Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. Am Heart J 2004;148:1068-1078.
26. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661.
27. Gandhi GY, Murad MH, Flynn DN, Erwin PJ, Cavalcante AB, Bay NH, Capes SE, Thorlund K, Montori VM, Devereaux PJ: Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials. 7. Mayo Clin Proc 2008;83:418-430.
28. Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation - NICE-SUGAR. http://www.thegeorgeinstitute.org/research/ criticalcare-&-trauma/research/normoglycaemiain-intensive-care-evaluation- nice.cfm.2008.
29. Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY). http://www.clinicaltrials.gov/ct/ show/NCT00220987.£2008.
30. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G: Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008;19:571-578.
31. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M: Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-3159.
32. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM: Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006;118:173-179.
33. Faustino EV, Apkon M: Persistent hyperglycemia in critically ill children. J Pediatr 2005;146:30-34.
34. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V: Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004;5:329-336.
35. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC: Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 2005;6:470-472.
36. Yung M, Wilkins B, Norton L, Slater A: Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 2008;9:147-152.
37. Tight Glycemic Control with Intensive Insulin Therapy in PICU. http://www.clinicaltrials.gov/ct2/show/NCT00214916.2008.
38. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ: Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care 2006;10:R19.
39. Dungan K, Chapman J, Braithwaite SS, Buse J: Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007;30:403-409.
40. Louie RF, Tang Z, Sutton, DV, Lee JH, Kost GJ: Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000;124:257-266.
41. Lacara T, Domagtoy C, Lickliter D, Quattrocchi K, Snipes L, Kuszaj J, Prasnikar M: Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care 2007;16:336-346.
42. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S: Fingerstick glucose determination in shock. Ann Intern Med 1991;114:1020-1024.
43. Vriesendorp TM, DeVries JH, Rosendaal F, Hoekstra JB: Severe hypoglycemia in critically ill: risk and outcomes. Crit Care Med 2008;36:1390-1391.
44. Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA: Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 2003;23:10681-10690.
45. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007;117:910-918.
46. Suh SW, Garnier P, Aoyama K, Chen Y, Swanson RA: Zinc release contributes to hypoglycemia-induced neuronal death. Neurobiol Dis 2004;16:538-545.
47. Suh SW, Aoyama K, Matsumori Y, Liu J, Swanson RA: Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 2005;54:1452-1458.
48. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T: Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998;18:5151-5159.
49. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.
50. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G: Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004;89:219-226.
51. Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G: Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 2002;87:5516-5523.
52. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G: Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007;92:3890-3897.
53. Klip A, Tsakiridis T, Marette A, Ortiz PA: Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 1994;8:43-53.
54. Sanchez-Alvarez R, Tabernero A, Medina JM: Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J Neurochem 2004;89:703-714.
55. Clerici C, Matthay MA: Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 2000;88:1890-1896.
56. Shikhman AR, Brinson DC, Valbracht J, Lotz MK: Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 2001;167:7001-7008.
57. Pekala P, Marlow M, Heuvelman D, Connolly D: Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 1990;265:18051-18054.
58. Quinn LA, McCumbee WD: Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 1998;177:94-102.
59. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004;114:1187-1195.
60. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005;365:53-59.
61. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005;11:304-311.
62. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van EE, Herijgers P, Mathieu C, Van den BG: Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006;55:1096-1105.
63. Lanza-Jacoby S, Wong SH, Tabares A, Baer D, Schneider T: Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochim Biophys Acta 1992;1124:233-240.
64. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C: Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000;181(suppl 3):S462-S472.
65. Carpentier YA, Scruel O: Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002;5:153-158.
66. Harris HW, Grunfeld C, Feingold KR, Rapp JH: Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696-702.
67. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van HE, Mathieu C, Van den BG: Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003;144:5329-5338.
68. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003;88:1082-1088.
69. Black CT, Hennessey PJ, Andrassy RJ: Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990;30:830-832.
70. Nielson CP, Hindson DA: Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38:1031-1035.
71. Perner A, Nielsen SE, Rask-Madsen J: High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003;29:642-645.
72. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den BG: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005;115:2277-2286.
73. Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den BG: Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 2005;33:504-510.
74. Vanhorebeek I, Peeters RP, Vander Perre S, Jans I, Wouters PJ, Skogstrand K, Hansen TK, Bouillon R, Van den Berghe G: Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 2006;91:3803-3813.
75. Vanhorebeek I, Langouche L, Van den Berghe G: Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007;132:268-278.